ADD-ONS / SCALES AND SCORES
CHA2DS2-VASc score
Created 08/12/2021, last revision 07/02/2023
- the CHA2DS2-VASc score helps to estimate the annual risk of a thromboembolic event in non-anticoagulated patients with non-valvular atrial fibrillation(AFib)
- patients with paroxysmal atrial fibrillation have a similar risk of stroke as patients with persistent or permanent forms [Hart 2000]
- annual stroke risk predetermined the choice of prophylactic medication → for initial assessment of the risk of thromboembolic complications, the CHA2DS2-VASc score is recommended instead of the older CHADS2 score
- many patients with a CHADS2 score of 0-1 have a CHA2DS2-VASc score ≥ 2 and are indicated for anticoagulant therapy [AFNET register – ESC Congress]
- low-risk patients with a CHA2DS2-VASc score of 0 (male) or 1 (female) do not require antithrombotic therapy
- oral anticoagulant therapy should be offered to those with ≥1 additional stroke risk factor. In secondary stroke prevention, patients have ≥ 2 points and automatically should receive anticoagulant therapy
|
CHA2DS2-VASc score and CHADS2 score
|
|||
|
CHA2DS2-VASc score
|
CHADS2 score |
||
|
C – CHF (Congestive Heart Failure) history (EF<40%)
|
1
|
1 | |
|
H – hypertension history
|
1
|
1 | |
|
A – age ≥ 75 years
|
2
|
1 | |
|
D – diabetes history
|
1
|
1 | |
|
S2 – stroke/TIA/thromboembolism history
|
2
|
2 | |
|
V – history of vascular disease (prior MI, PAD, or aortic/carotid plaque)
|
1
|
– | |
|
A – age 65-74 years
|
1
|
– | |
|
Sc (sex category)
|
1 (female)
|
– | |
| CHA2DS2-VASc | CHADS2 |
|
Annual stroke risk
[Eckmann,2011] |
Annual stroke risk
Gage, JAMA 2001] |
|
0 – 0%
1 – 1.35% **
2 – 2.2%
3 – 3.2%
4 – 4.0%
5 – 6.7%
6 – 9.8% 7 – 9.6% 8 – 6.7% 9 – 15.2% |
0 – 1.9%
1 – 2.8% 2 – 4.0% 3 – 5.9% 4 – 8.5% 5 – 12.5% 6 – 18.2% |
** according to some reports, the risk of CHA2DS2-VASc score is lower – 0.2-0.7% [Friberg, 2015]
- a limitation of both scales is the lack of some critical information:
- TEE – spontaneous echo contrast or left atrial thrombus?
- brain CT/MRI – clinically silent infarcts? microbleeds on GRE?
- assessment of individual bleeding risk (especially intracranial)
- in addition, the scales are based on data from patients taking warfarin; a lower bleeding risk can be assumed for DOACs
| Content available only for logged-in subscribers (registration will be available soon) |
